IL13 and gastric cancer: In fact, a mixed Th1/Th2 immune response is associated with non-atrophic chronic gastritis, while a prevalent Th2 immune response, mostly IL-13-mediated, characterizes patients with intestinal metaplasia and intestinal-type gastric cancer [38].